AI Article Synopsis

  • Pefloxacin is an advanced quinolone antibiotic known for its strong in vitro antibacterial activity and wide effectiveness against various bacteria.
  • In a study involving 35 patients, pefloxacin was administered, and its levels in bronchial mucus were compared to those in plasma, with samples taken at different times.
  • Results showed high concentrations of pefloxacin in bronchial mucus, typically over 5 mg/l, and the ratio of mucus to plasma concentrations was consistently high, indicating excellent diffusion of the drug into the mucus.

Article Abstract

Pefloxacin is a new quinolone with significant in vitro antibacterial activity and a broad spectrum. It was included in an extensive study of antibiotic diffusion into bronchial mucus. Pefloxacin was given to 35 patients divided into five groups according to the timing of sputum sampling. Plasma specimens were taken simultaneously. Pefloxacin was measured by microbiological assay. Mean pefloxacin concentrations in bronchial mucus was high, exceeding 5 mg/l. Concentrations on the first and third days were similar. The ratio of mucus concentrations to plasma concentrations was high in each case, around or often above 1. These findings show that diffusion of pefloxacin into bronchial mucus is outstanding.

Download full-text PDF

Source

Publication Analysis

Top Keywords

bronchial mucus
12
diffusion bronchial
8
pefloxacin
5
[pefloxacine diffusion
4
bronchial
4
bronchial mucus]
4
mucus] pefloxacin
4
pefloxacin quinolone
4
quinolone vitro
4
vitro antibacterial
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!